All Cancer articles – Page 5
-
BusinessLilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
BusinessCelgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
-
PodcastCaesium chloride
A compound found in mineral water that is also used in medical treatments and solar cells
-
NewsEuropean chemicals body links titanium dioxide to cancer
Chemical found in everything from paint to toothpaste added to list of suspected carcinogens over inhalation risk
-
BusinessFirst biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
BusinessSeattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
BusinessJ&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
NewsEx-Harvard postdoc sues university for drug royalties
Former Harvard chemist says he lost out on millions after the technology he worked on was licensed to Merck & Co
-
NewsAction on white asbestos blocked by top exporters
Chrysotile will not be added to Rotterdam Convention’s list of hazardous substances
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
NewsGlyphosate is not carcinogenic, EU chemicals association concludes
Evaluation clears the way for long term authorisation of herbicide
-
-
BusinessUniversity–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
ResearchPersonalised medicine boost as cancer drug monitored in real-time
Aptamer-based sensors can track levels of small molecules in rats as the go about their business
-
BusinessIpsen to buy Merrimack’s cancer drugs
$1bn deal covers two liposome-encapsulated formulations of approved therapies
-
BusinessTakeda to buy cancer specialist Ariad
Japan’s largest drug company agrees $5.2bn deal to expand oncology portfolio and boost pipeline
-
NewsFears that gene-editing cancer trials are premature
Warnings from geneticists that Crispr trial failures could knock promising technique’s prospects
-
BusinessDuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
PodcastBromodeoxyuridine
Kat Arney illuminates the story of a molecular ‘highlighter pen’ for growing cells
-
NewsWHO cancer agency criticised for outdated chemical risk methods
Criticism of carcinogenicity assessments that place processed meat in the same category as mustard gas